Skip to search formSkip to main contentSkip to account menu

rasagiline

Known as: (R)-Indan-1-yl-prop-2-ynyl-amine, rasagiline [Chemical/Ingredient], RAS 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
Rasagiline has been studied as a Parkinson disease (PD) neuroprotective agent in 2 major clinical trials, utilizing the delayed… 
Highly Cited
2002
Highly Cited
2002
Recently, we reported specific brain gene expression changes in the chronic MPTP model in the late stage of degeneration… 
Review
2001
Review
2001
Rasagiline (N-propargyl-1-(R)-aminoindan) is a selective, irreversible monoamine oxidase B (MAO B) inhibitor which has been… 
Highly Cited
2001
Highly Cited
2001
An endogenous dopaminergic neurotoxin, N‐methyl(R)salsolinol, was found to induce apoptosis in human dopaminergic SH‐SY5Y cells… 
Highly Cited
2001
Highly Cited
2001
Summary. The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) has been shown to induce parkinsonism in man and non… 
Highly Cited
1996
Highly Cited
1996
Rasagiline [R(+)-N-propargyl-1-aminoindane] is a selective irreversible inhibitor of MAO-B which is not metabolised to…